Get startedLog in
    Picture of Beijing Tong Ren Tang Chinese Medicine Co logo

    3613 — Beijing Tong Ren Tang Chinese Medicine Co Cashflow Statement

    0.000.00%
    hk flag iconLast trade - 00:00
    HealthcareAdventurousMid CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Beijing Tong Ren Tang Chinese Medicine Co, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    HKAS
    HKAS
    HKAS
    HKAS
    HKAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line686778826688630
    Depreciation
    Amortisation
    Non-Cash Items-14.46.6-7.91-44.1-52.4
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-633-77.8-346-265-883
    Change in Accounts Receivable
    Change in Inventories
    Change in Payable / Accrued Expenses
    Other Operating Cash Flow
    Cash from Operating Activities116777547461-217
    Capital Expenditures-12.9-23.4-38.5-21.9-43.2
    Purchase of Fixed Assets
    Other Investing Cash Flow Items520-242374-1,0571,398
    Acquisition of Business
    Sale of Business
    Sale of Fixed Assets
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities507-266335-1,0791,355
    Financing Cash Flow Items-26.4-27.5-35.3-37.2-15.1
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-264-279-535-372-355
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash369234331-991773